ImmuPharma PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Tim McCarthy, was filed 24 Aug 2021.
ImmuPharma PLC: what insiders have been doing
ImmuPharma PLC is a listed company. Its insiders report their share dealings to RNS (LSE). The past year has been quiet: not a single insider filing for ImmuPharma PLC. The previous disclosure was published on 24 August 2021.
Over the whole record (from 2013), the tally stands at 5 purchases and 2 sales.
Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Since the insiders bought
- -20.5%Entry £0.08 · Close at T+365 £0.06
- -20.5%Entry £0.08 · Close at T+365 £0.06
- -20.5%Entry £0.08 · Close at T+365 £0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 125,000 shares@ £0.0799100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0033711010FCA-NSM:4088513-1Canonical exit: 22 Nov 2021 (T+90)
- 250,000 shares@ £0.0826100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0033711010FCA-NSM:4088513-0Canonical exit: 21 Nov 2021 (T+90)
- 125,000 shares@ £0.08100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0033711010FCA-NSM:4088513-2Canonical exit: 21 Nov 2021 (T+90)
- 140,000 shares@ £0.082100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0033711010FCA-NSM:4088513-3Canonical exit: 21 Nov 2021 (T+90)
- 30,000 shares@ £0.0789100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0033711010FCA-NSM:4088513-4Canonical exit: 21 Nov 2021 (T+90)
- 62,169 shares@ £0.57FCA-NSM:LSE20130128160342_011470948_20200330164702753
- 62,169 shares@ £0.57FCA-NSM:LSE20130128131847_011470622_20200330164702749
7 of 7 declarations
About ImmuPharma PLC
ImmuPharma PLC is a biopharmaceutical company focused on developing treatments for autoimmune diseases and cancers. It specializes in innovative therapies based on peptides.
